Clinical Trial Update: Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and anti-tumor activity of PolyPEPI1018 plus atezolizumab in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• PolyPEPI1018 (PolyPEPI1018)

Snippet

Sponsor: Treos Bio Limited | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING